Interestingly, our current study revealed that CD14 monocytes in T2D exhibited a significantly higher pro-inflammatory score and enriched pathways associated with MHC class II protein complex binding and RETN-CAP1 interaction compared to the non-diabetes. The gene discussed is CD14; the disease is diabetes mellitus.